MAY 24, 2017 6:00 AM PDT

Exploring Pharmacological Interactions with Matrix: The Innovations and Challenges of NCATS Drug Combination HTS Platform

Presented at: Lab Automation 2017
Speaker
  • Research Scientist, NCATS/NIH
    Biography
      Kelli Wilson is a Research Scientist in the Information Technology Research Branch at the National Center for Advancing Translational Science (NCATS) at the NIH. In this role, Kelli performs high throughput screening using a variety of automated platforms, with a focus on acoustic dispensing for drug combination screening using the EDC Biosystems ATS-100 and the Labcyte Echo. Kelli received her PhD in Cellular and Molecular Medicine from the Johns Hopkins School of Medicine. Her PhD thesis was entitled "The application of a characterized pre-clinical Glioblastoma oncosphere model to in vitro and in vivo therapeutic testing". Kelli has expertise in cancer biology, high throughput screening, drug repurposing, and acoustic dispensing technologies.

    Abstract

    Acoustic dispensing technology has allowed for compound plating to be highly customizable depending upon scientific needs.  The ability to dispense compounds from a single well to any well of a destination plate has made plating drug combinations a possibility. At NCATS, we have applied acoustic dispensing technology to create drug combination matrices, grids which contain combinations of 2 compounds at variable ratios to allow for exploration of drug synergy.  This technology required significant in house software development and integration with our existing robotic infrastructure. We now have applied this technology to drug repurposing projects for treating cancer, malaria, ebola virus and zika virus, which has been included in publications and provided the basis for ongoing clinical trials.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    DEC 07, 2020 9:00 AM PST
    DEC 07, 2020 9:00 AM PST
    Date: December 7, 2020 Time: 9:00am (PST), 12:00pm (EST) The simultaneous detection of biomarkers on tissue samples plays a fundamental role in the study of the tumor microenvironment. Multi...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    MAY 24, 2017 6:00 AM PDT

    Exploring Pharmacological Interactions with Matrix: The Innovations and Challenges of NCATS Drug Combination HTS Platform

    Presented at: Lab Automation 2017

    No demographic data is available yet for this event.


    Show Resources
    Loading Comments...
    Show Resources